SomnoMed (SomnoMed) Net Income Including Noncontrolling Interests : $-7.10 Mil (TTM As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is SomnoMed Net Income Including Noncontrolling Interests?

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

SomnoMed's Net Income Including Noncontrolling Interests for the six months ended in Dec. 2023 was $-4.25 Mil. Its Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Dec. 2023 was $-7.10 Mil.

SomnoMed Net Income Including Noncontrolling Interests Historical Data

The historical data trend for SomnoMed's Net Income Including Noncontrolling Interests can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SomnoMed Net Income Including Noncontrolling Interests Chart

SomnoMed Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Net Income Including Noncontrolling Interests

Get a 7-Day Free Trial

-11.42

-0.77

-0.91

-3.12

-5.37

SomnoMed Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Net Income Including Noncontrolling Interests	Get a 7-Day Free Trial															-2.11	-1.05	-2.53	-2.86	-4.25

SomnoMed Net Income Including Noncontrolling Interests Calculation

Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-7.10 Mil.

SomnoMed Net Income Including Noncontrolling Interests Related Terms

Thank you for viewing the detailed overview of SomnoMed's Net Income Including Noncontrolling Interests provided by GuruFocus.com. Please click on the following links to see related term pages.

SomnoMed (SomnoMed) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SomnoMed Ltd (OTCPK:SOMNF) » Definitions » Net Income Including Noncontrolling Interests

Comparable Companies

Traded in Other Exchanges

RJV:Germany SOM:Australia

Address

20 Clarke Street, Level 3, Crows Nest, Sydney, NSW, AUS, 2065

Website

https://www.somnomed.com/au

SomnoMed Ltd produces and sells oral treatment of sleep-related disorder devices. It manufactures and designs premium oral appliances for the treatment of sleep-disordered breathing relieving conditions. Its products include SomnoDent, Som Tabs, Som Morning Repositioner and others. Its geographical segments include North America, Europe, and Asia-Pacific. Business operations consist of the production and sale of products treating sleep-disordered breathing, which is the only reportable segment. Substantial revenue is realized from the European region.

SomnoMed (SomnoMed) Headlines

From GuruFocus

SomnoMed's North America Q1 revenue growth leads the way

By PRNewswire PRNewswire • 10-28-2022

SomnoMed posts record Q4 and delivers on FY22 revenue guidance

By PRNewswire PRNewswire • 07-26-2022